Tactile Systems Technology, Inc.

NasdaqGM:TCMD 株式レポート

時価総額：US$523.7m

Tactile Systems Technology 配当と自社株買い

配当金 基準チェック /06

Tactile Systems Technology配当金を支払った記録がありません。

主要情報

n/a

配当利回り

4.8%

バイバック利回り

総株主利回り4.8%
将来の配当利回りn/a
配当成長n/a
次回配当支払日n/a
配当落ち日n/a
一株当たり配当金n/a
配当性向n/a

最近の配当と自社株買いの更新

Recent updates

TCMD: Lymphedema Execution And Multi Year Guidance Will Support Continued Upside

Analysts have lifted the consolidated price target for Tactile Systems Technology to around $38, supported by higher projections for revenue growth, improved profit margins, and a lower assumed future P/E multiple following recent Q4 upside and updated multi year guidance. Analyst Commentary Recent Street research on Tactile Systems Technology highlights a range of views on execution, growth prospects, and valuation following the Q4 results and updated multi year guidance.

Should You Think About Buying Tactile Systems Technology, Inc. (NASDAQ:TCMD) Now?

Apr 18
Should You Think About Buying Tactile Systems Technology, Inc. (NASDAQ:TCMD) Now?

TCMD: Lymphedema Momentum And Q4 Execution Will Drive Multi Year Upside

The updated analyst price target for Tactile Systems Technology has been set at $38. This reflects analysts' reactions to recent Q4 outperformance, higher long-term estimates, and ongoing attention to productivity, patient referrals, and the lymphedema business.

TCMD: Lymphedema Momentum And Q4 Execution Will Support Multi Year Upside

Analysts have lifted the consolidated price target for Tactile Systems Technology to $38, reflecting a series of Street target increases into the $32 to $42 range, supported by recent Q4 outperformance, updated multi year guidance, and progress in productivity and cost controls. Analyst Commentary Street commentary around Tactile Systems Technology is mixed, with several bullish analysts lifting targets on the back of Q4 execution and longer term guidance, while more cautious voices question how much upside remains after the post earnings re rating.

TCMD: Lymphedema Momentum And Q4 Execution Will Support Ongoing Upside Potential

Analysts have nudged their average price target for Tactile Systems Technology to $38. This reflects stronger recent Q4 execution, raised long term estimates and ongoing improvements in productivity, patient referrals and cost controls.

TCMD: Lymphedema Momentum And Q4 Execution Will Support Measured Turnaround Expectations

The analyst fair value estimate for Tactile Systems Technology has been raised from $29.75 to $38.00, reflecting higher Street price targets in the $32 to $42 range as analysts cite recent Q4 upside, improved productivity and cost controls, and ongoing strength in the lymphedema business. Analyst Commentary Street research on Tactile Systems Technology is generally constructive, with higher fair value assumptions linked to recent Q4 performance, execution on productivity and cost controls, and expectations around the lymphedema business.

TCMD: Index Inclusion And Stable Outlook Will Shape Measured Turnaround Expectations

Analysts have maintained their fair value estimate for Tactile Systems Technology at $29.75 per share. They cited only very small adjustments to assumptions regarding the discount rate, revenue growth, profit margins, and future P/E multiples, rather than any change in the core outlook.

TCMD: Turnaround Momentum And Buyback Will Test Q3 Outperformance Sustainability

Analysts have raised their price targets on Tactile Systems Technology to a roughly mid to high $20s to low $30s range, citing stronger than expected Q3 results, improved productivity, sales force expansion, new products, and better reimbursement trends that together support a higher fair value assessment. Analyst Commentary Recent research points to a more constructive view on Tactile Systems Technology following its Q3 outperformance, with several firms raising price targets and upgrading ratings based on execution and perceived upside to fair value.

TCMD: Q3 Turnaround Momentum And Buyback Will Face Execution Risk

Analysts have raised their price target on Tactile Systems Technology to about $29.75 from $24, citing stronger recent earnings performance, expectations for operational improvements, and support for a higher future P/E multiple. Analyst Commentary Recent research updates on Tactile Systems Technology highlight a clear shift toward a more constructive stance, with multiple firms lifting price targets after Q3 results and pointing to both execution progress and valuation support.

Investors Appear Satisfied With Tactile Systems Technology, Inc.'s (NASDAQ:TCMD) Prospects As Shares Rocket 28%

Dec 18
Investors Appear Satisfied With Tactile Systems Technology, Inc.'s (NASDAQ:TCMD) Prospects As Shares Rocket 28%

TCMD: Q3 Outperformance And Buyback Will Mask Limited Upside Ahead

Analysts have raised their price target on Tactile Systems Technology by about $8.50 to roughly $32 per share, citing significant Q3 outperformance, improving productivity and reimbursement trends, and expectations for a return to double digit growth by 2026. Analyst Commentary Recent research updates reflect a notably more constructive stance on Tactile Systems Technology, with bullish analysts pointing to operational momentum, clearer reimbursement visibility, and a sizable underpenetrated patient pool as key drivers of potential upside in the shares.

TCMD: Q3 Outperformance And Buyback Plan Will Shape Turnaround Outlook

Analysts have raised their price expectations for Tactile Systems Technology toward the low to mid $30 range, citing a massive Q3 outperformance, consistent estimate beats, and growing confidence in a 2026 growth reacceleration and higher sustainable earnings power. Analyst Commentary Recent Street research reflects a broadly constructive stance on Tactile Systems Technology following its strong Q3 performance and improving fundamentals.

TCMD: Sustained Product Execution And Buyback Plan Set To Shape Outlook

Analysts have raised their price target on Tactile Systems Technology significantly, from approximately $16.83 to $24.00. They cite strong quarterly outperformance and growing confidence in the company’s turnaround and future growth prospects.

Results: Tactile Systems Technology, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Nov 06
Results: Tactile Systems Technology, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

TCMD: Market Leadership And Coverage Momentum Will Drive Expansion Into Underserved Patients

Narrative Update on Tactile Systems Technology Analysts have reaffirmed their price target for Tactile Systems Technology at $16.83 per share. They cite the company's leadership in key market segments and anticipated growth acceleration as a result of recent strategic improvements.

At-home Healthcare And Workflow Automation Will Expand Patient Reach

Analysts have maintained their price target for Tactile Systems Technology at $23.50. They cite the company's leading positions in key device markets and an improved outlook following recent strategic adjustments.

At-home Healthcare And Workflow Automation Will Expand Patient Reach

Analysts have raised their fair value estimate for Tactile Systems Technology from $13.50 to $16.83 per share. The change is attributed to optimism about the company's strengthened market leadership and the potential for renewed growth following recent strategic improvements.

When Should You Buy Tactile Systems Technology, Inc. (NASDAQ:TCMD)?

Oct 04
When Should You Buy Tactile Systems Technology, Inc. (NASDAQ:TCMD)?

Tactile Systems Technology, Inc.'s (NASDAQ:TCMD) Shares Leap 28% Yet They're Still Not Telling The Full Story

Aug 29
Tactile Systems Technology, Inc.'s (NASDAQ:TCMD) Shares Leap 28% Yet They're Still Not Telling The Full Story

Tactile Systems Technology's (NASDAQ:TCMD) Soft Earnings Don't Show The Whole Picture

May 12
Tactile Systems Technology's (NASDAQ:TCMD) Soft Earnings Don't Show The Whole Picture

Slammed 28% Tactile Systems Technology, Inc. (NASDAQ:TCMD) Screens Well Here But There Might Be A Catch

May 08
Slammed 28% Tactile Systems Technology, Inc. (NASDAQ:TCMD) Screens Well Here But There Might Be A Catch

Why Tactile Systems Technology, Inc. (NASDAQ:TCMD) Could Be Worth Watching

May 07
Why Tactile Systems Technology, Inc. (NASDAQ:TCMD) Could Be Worth Watching

Tactile Systems Technology: Interesting Devices Company, Need More Clarity

Apr 07

Tactile Systems Technology (NASDAQ:TCMD) Has A Rock Solid Balance Sheet

Feb 23
Tactile Systems Technology (NASDAQ:TCMD) Has A Rock Solid Balance Sheet

Investors Appear Satisfied With Tactile Systems Technology, Inc.'s (NASDAQ:TCMD) Prospects As Shares Rocket 26%

Nov 25
Investors Appear Satisfied With Tactile Systems Technology, Inc.'s (NASDAQ:TCMD) Prospects As Shares Rocket 26%

Tactile Systems Technology, Inc. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next

Nov 07
Tactile Systems Technology, Inc. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next
User avatar

Nimbl Approval And Tech Investments Propel Growth Amid Shrinking Margins And Operational Risks

Investments in technology and workflow improvements, alongside FDA approval for Nimbl, indicate a strong focus on innovation and market expansion.

Investors Holding Back On Tactile Systems Technology, Inc. (NASDAQ:TCMD)

Jul 17
Investors Holding Back On Tactile Systems Technology, Inc. (NASDAQ:TCMD)

US$20.67: That's What Analysts Think Tactile Systems Technology, Inc. (NASDAQ:TCMD) Is Worth After Its Latest Results

May 09
US$20.67: That's What Analysts Think Tactile Systems Technology, Inc. (NASDAQ:TCMD) Is Worth After Its Latest Results

Tactile Systems Technology, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Feb 23
Tactile Systems Technology, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Does Tactile Systems Technology (NASDAQ:TCMD) Have A Healthy Balance Sheet?

Oct 10
Does Tactile Systems Technology (NASDAQ:TCMD) Have A Healthy Balance Sheet?

Capital Allocation Trends At Tactile Systems Technology (NASDAQ:TCMD) Aren't Ideal

Sep 16
Capital Allocation Trends At Tactile Systems Technology (NASDAQ:TCMD) Aren't Ideal

Is It Time To Consider Buying Tactile Systems Technology, Inc. (NASDAQ:TCMD)?

Jul 13
Is It Time To Consider Buying Tactile Systems Technology, Inc. (NASDAQ:TCMD)?

Are Investors Undervaluing Tactile Systems Technology, Inc. (NASDAQ:TCMD) By 26%?

May 10
Are Investors Undervaluing Tactile Systems Technology, Inc. (NASDAQ:TCMD) By 26%?

Is Tactile Systems Technology (NASDAQ:TCMD) Using Too Much Debt?

Feb 16
Is Tactile Systems Technology (NASDAQ:TCMD) Using Too Much Debt?

決済の安定と成長

配当データの取得

安定した配当: TCMDの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。

増加する配当: TCMDの配当金が増加しているかどうかを判断するにはデータが不十分です。

配当利回り対市場

Tactile Systems Technology 配当利回り対市場
TCMD 配当利回りは市場と比べてどうか？
セグメント配当利回り
会社 (TCMD)n/a
市場下位25% (US)1.4%
市場トップ25% (US)4.2%
業界平均 (Medical Equipment)2.2%
アナリスト予想 (TCMD) (最長3年)n/a

注目すべき配当: TCMDは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。

高配当: TCMDは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。

株主への利益配当

収益カバレッジ: TCMDの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。

株主配当金

キャッシュフローカバレッジ: TCMDが配当金を報告していないため、配当金の持続可能性を計算できません。

高配当企業の発掘

7D

1Y

7D

1Y

7D

1Y

企業分析と財務データの現状

データ最終更新日（UTC時間）
企業分析2026/05/01 23:31
終値2026/05/01 00:00
収益2025/12/31
年間収益2025/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Tactile Systems Technology, Inc. 5 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。12

アナリスト機関
null nullArgus Research Company
Kyle BauserB. Riley Securities, Inc.
Anderson SchockB. Riley Securities, Inc.